US EditionAlkermes, Novartis Exempt Additional States from 340B Contract Pharmacy Restrictions - 340B Report
Summary by 340breport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Alkermes, Novartis Exempt Additional States from 340B Contract Pharmacy Restrictions - 340B Report
Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...] The post Alkermes, Novartis Exempt Additional States from 340B Contract Pharmacy Restrictions appeared first on 340B Report.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
